WuXi AppTec to divest clinical services to focus on manufacturing businessnews2025-10-27T13:42:32+00:00October 27th, 2025|Endpoints News|
FDA uncovers unauthorized Indian API warehouse with lizards, catsnews2025-10-24T18:15:00+00:00October 24th, 2025|Endpoints News|
Merck KGaA to end API work at Irish plant after ‘strategic portfolio review’news2025-10-23T16:24:04+00:00October 23rd, 2025|Endpoints News|
Lonza expects more CDMO contracts; Galderma’s $650M US commitmentnews2025-10-23T15:55:08+00:00October 23rd, 2025|Endpoints News|
Drugmakers push to break ground after Trump’s 100% tariff threatnews2025-10-23T13:27:43+00:00October 23rd, 2025|Endpoints News|
Thermo Fisher, Danaher stand to gain from drugmakers’ onshoring effortsnews2025-10-22T17:11:30+00:00October 22nd, 2025|Endpoints News|
Chemify raises $50M+ Series B to scale molecule-making businessnews2025-10-21T12:00:17+00:00October 21st, 2025|Endpoints News|
Merck KGaA is open to more acquisitions, but not for its CDMO unitnews2025-10-16T15:18:38+00:00October 16th, 2025|Endpoints News|
AstraZeneca opens $445M expansion of Lokelma factory; Avidity Bio delays BLA for Duchenne drugnews2025-10-16T14:16:53+00:00October 16th, 2025|Endpoints News|
BioNTech to get up to €95M in EU funding for a mRNA vaccine site in Africa news2025-10-15T16:07:33+00:00October 15th, 2025|Endpoints News|
